Literature DB >> 29900

Activation of soluble splenic cell guanylate cyclase by prostaglandin endoperoxides and fatty acid hydroperoxides.

G Graff, J H Stephenson, D B Glass, M K Haddox, N D Goldberg.   

Abstract

Purified prostaglandin endoperoxides (PGG2 and PGH2) and hydroperoxides (15-OOH-PGE2) as well as fatty acid hydroperoxides (12-OOH-20:4, 15-00H-20:4, and 13-OOH-18:2) were examined as effectors of soluble splenic cell guanylate cyclase activity. The procedures described (in the miniprint supplement) for the preparation, purification, and characterization of these components circumvented the use of diethyl ether which obscured effects of lipid effectors because of contaminants presumed to be ether peroxides which were stimulatory to the cyclase. Addition of prostaglandin endoperoxides or fatty acid hydroperoxides to the reaction mixture led to a time-dependent activation of guanylate cyclase activity; 2.5- to 5-fold stimulation was seen during the first 6 min. The degree of stimulation and rate of activation were dependent on the concentration of the fatty acid effector; when initial velocities (6 min) were assessed half-maximal stimulation was achieved in the range of 2 to 3 micrometer. However, by extending the incubation time to 90 min similar maximal increases in specific activity could be achieved with 3 or 10 micrometer PGG2 or PGH2. Activation of guanylate cyclase upon addition of prostaglandin endoperoxides or fatty acid hydroperoxides was prevented or reversed by the thiol reductants dithiothreitol (3 to 5 mM) or glutathione (10 to 15 mM). Na2S2O4, not known as an effective reducing agent of disulfides, prevented but was relatively ineffective in reversing activation after it had been induced by PGG2. Pretreatment of the enzyme preparation with increasing concentrations of N-ethylmaleimide in the range of 0.01 to 1.0 mM prevented activation by PGG2 without affecting basal guanylate cyclase activity. These observations indicate that fatty acid hydroperoxides and prostaglandin endoperoxides promote activation of the cyclase by oxidation of enzyme-related thiol functions. In contrast PGE2, PGF2a, hydroxy fatty acids (13-OH-18:2, 12-OH-20:4) as well as saturated (18:0) monoenoic (18:1), dienoic (18:2), and tetraenoic (20:4) fatty acids were ineffective in promoting cyclase activation in the range of 1 to 10 micrometer. Studies to identify the species of the rapidly metabolized prostaglandin endoperoxides that serve as effectors of the cyclase indicated that PGG2 but not 15-OOH-PGE2 (the major buffer-rearrangement product of PGG2) is most likely an activator. In the case of PGH2, a rapidly generated (30 s) metabolite of PGH2 was found which contained a hydroperoxy or endoperoxy functional group and was equally as effective as PGH2 as an apparent activator of the enzyme. The combined effects of PGG2 and dehydroascorbic acid, another class of activator, exhibited additivity with respect to the rate at which the time-dependent activation was induced. These results suggest that activation of soluble guanylate cyclase from splenic cells can be achieved by the oxidation of sulfhydryl groups that may be associated with specific hydrophobic sites of the enzyme or a related regulatory component.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29900

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation.

Authors:  K Kondo; J A Mitchell; G de Nucci; J R Vane
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats.

Authors:  L Rothermund; A Friebe; M Paul; D Koesling; R Kreutz
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Colocalization of the genes coding for the alpha 3 and beta 3 subunits of soluble guanylyl cyclase to human chromosome 4 at q31.3-q33.

Authors:  G Giuili; N Roechel; U Scholl; M G Mattei; G Guellaen
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

Review 4.  Metabolites of arachidonic acid.

Authors:  W F Stenson; C W Parker
Journal:  Clin Rev Allergy       Date:  1983-09

5.  Inhibitory effects of mepacrine and eicosatetraynoic acid on cyclic GMP elevations caused by calcium and hormonal factors in rat ductus deferens.

Authors:  C Spies; K D Schultz; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-02       Impact factor: 3.000

Review 6.  Cellular and molecular aspects of immune system aging.

Authors:  D L Doggett; M P Chang; T Makinodan; B L Strehler
Journal:  Mol Cell Biochem       Date:  1981-07       Impact factor: 3.396

7.  Induction of prostacyclin biosynthesis is closely associated with increased guanosine 3',5'-cyclic monophosphate accumulation in cultured human endothelium.

Authors:  A F Brotherton
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

Review 8.  Redox regulation of guanylate cyclase and protein kinase G in vascular responses to hypoxia.

Authors:  Boon Hwa Neo; Sharath Kandhi; Mansoor Ahmad; Michael S Wolin
Journal:  Respir Physiol Neurobiol       Date:  2010-09-08       Impact factor: 1.931

9.  Role of lipoxygenase in the O2-dependent activation of soluble guanylate cyclase from rat lung.

Authors:  A A White; D B Karr; C S Patt
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

10.  13-Hydroperoxylinoleic acid inhibits rat liver glyoxalase II.

Authors:  E Gillespie
Journal:  Inflammation       Date:  1981-09       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.